FC
GSK icon

Ferris Capital’s GSK GSK Stock Holding History

Ferris Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,315
Closed -$121K – 349
2019
Q1 		$121K Hold
2,315
– – 0.04% 200
2018
Q4 		$111K Hold
2,315
– – 0.05% 194
2018
Q3 		$116K Hold
2,315
– – 0.05% 198
2018
Q2 		$117K Hold
2,315
– – 0.05% 189
2018
Q1 		$113K Buy
+2,315
New +$108K 0.05% 211
2017
Q3 		– Sell
-2,600
Closed -$140K – 325
2017
Q2 		$140K Buy
+2,600
New +$139K 0.07% 173

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Ferris Capital's GSK Position: Q2 2019 in Review

Ferris Capital sold out of GSK (GSK) in Q2 2019, closing a stake of 2,315 shares — an estimated $121K sold.

Ferris Capital first reported a position in GSK in Q2 2017 and held it in 6 quarters. The position peaked at $140K in Q2 2017. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

  • Ferris Capital reported no remaining GSK position as of Q2 2019 after selling out during the quarter.
  • Ferris Capital sold 2,315 GSK shares in Q2 2019, an estimated $121K.
  • Ferris Capital first reported a position in GSK in Q2 2017 and held it in 6 quarters.
  • Ferris Capital's GSK position peaked at $140K in Q2 2017.
  • 804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on Ferris Capital's 13F filing for Q2 2019, filed 18 Jul 2019.